These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31809707)

  • 1. Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
    Gawron LM; Gero A; Kushner KL; Turok DK; Sanders JN
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S891-S892. PubMed ID: 31809707
    [No Abstract]   [Full Text] [Related]  

  • 2. Updates in hormonal emergency contraception.
    Shrader SP; Hall LN; Ragucci KR; Rafie S
    Pharmacotherapy; 2011 Sep; 31(9):887-95. PubMed ID: 21923590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
    Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
    Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency contraception.
    Hsiang D; Dunn S
    CMAJ; 2016 Dec; 188(17-18):E536. PubMed ID: 27821461
    [No Abstract]   [Full Text] [Related]  

  • 5. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception.
    Richardson AR; Maltz FN
    Clin Ther; 2012 Jan; 34(1):24-36. PubMed ID: 22154199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulipristal acetate as an emergency contraceptive agent.
    Martinez AM; Thomas MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1937-42. PubMed ID: 22770536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulipristal acetate for emergency contraception.
    Snow SE; Melillo SN; Jarvis CI
    Ann Pharmacother; 2011 Jun; 45(6):780-6. PubMed ID: 21666089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency contraception review: evidence-based recommendations for clinicians.
    Cleland K; Raymond EG; Westley E; Trussell J
    Clin Obstet Gynecol; 2014 Dec; 57(4):741-50. PubMed ID: 25254919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy access to Ulipristal acetate in major cities throughout the United States.
    Shigesato M; Elia J; Tschann M; Bullock H; Hurwitz E; Wu YY; Salcedo J
    Contraception; 2018 Mar; 97(3):264-269. PubMed ID: 29097224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with oral emergency contraception since the OTC switch in Germany.
    Kiechle M; Neuenfeldt M
    Arch Gynecol Obstet; 2017 Mar; 295(3):651-660. PubMed ID: 27896473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
    Lete I; Doval JL; Pérez-Campos E; Alonso MJ; Sellers G; Sánchez-Borrego R
    Gynecol Endocrinol; 2019 Jul; 35(7):582-585. PubMed ID: 30614295
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergency contraception.
    Am Fam Physician; 2014 Apr; 89(7):Online. PubMed ID: 24695612
    [No Abstract]   [Full Text] [Related]  

  • 13. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
    Glasier AF; Cameron ST; Fine PM; Logan SJ; Casale W; Van Horn J; Sogor L; Blithe DL; Scherrer B; Mathe H; Jaspart A; Ulmann A; Gainer E
    Lancet; 2010 Feb; 375(9714):555-62. PubMed ID: 20116841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls of adapting emergency contraception CEU guidance.
    Webb A; McGough P; Melvin L
    J Fam Plann Reprod Health Care; 2012 Oct; 38(4):270. PubMed ID: 23027990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse].
    Jamin C
    Gynecol Obstet Fertil; 2015 Mar; 43(3):242-7. PubMed ID: 25703406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulipristal and embryotoxicity--an alternative viewpoint.
    Calis KA
    Pharmacotherapy; 2012 Sep; 32(9):e176; discussion 176-7. PubMed ID: 22949143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Postcoital contraception with steroid hormones].
    Köhler G; Göretzlehner G
    Zentralbl Gynakol; 1984; 106(17):1173-81. PubMed ID: 6437101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-Based Contraception: Common Questions and Answers.
    Paradise SL; Landis CA; Klein DA
    Am Fam Physician; 2022 Sep; 106(3):251-259. PubMed ID: 36126006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulipristal acetate compared to levonorgestrel emergency contraception among current oral contraceptive users: a cost-effectiveness analysis.
    Bullard KA; Edelman AB; Williams SM; Rodriguez MI
    Contraception; 2019 Sep; 100(3):222-227. PubMed ID: 31102631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.